hims semaglutide california Novo Nordisk Drops & Hers: Inside the Compounded GLP-1 Crisis Hims & Hers announces access

Cardiovascular disease (CVD) is the main cause of death and disability among people with type 2 diabetes.[2] Adults with type 2 diabetes are two to four times more likely to develop CVD than adults without diabetes.[3] The FDA's decision on semaglutide is based on results from the SUSTAIN 6 cardiovascular outcomes trial (CVOT), which examined the cardiovascular safety of adding Ozempic or placebo to standard-of-care in adults with type 2 diabetes and established cardiovascular disease

There is still lots of opportunity to support patients with medical weight loss

Semaglutide offers more gradual dose increases, so it may help better reduce side effects, but it also requires more patience because it may take longer before seeing substantial results

There is limited specific research on the direct impact of semaglutide on the menstrual cycle

Preclinical evaluation of Trichilia catigua extracts on the central nervous system of mice

Under medical supervision at ReJuv, these once-weekly injections can help patients with a BMI over 27 (with weight-related conditions) or over 30 (without) lose weight more effectively than lifestyle changes alone